DAFNA Capital Management’s LAVA Therapeutics LVTX Stock Holding History

DAFNA Capital Management’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-128,335	Closed	-$379K	–	90
2022 Q2	$379K	Sell	128,335 -10,997	-8%	-$38.1K	0.1%	81
2022 Q1	$613K	Hold	139,332	–	–	0.16%	80
2021 Q4	$766K	Hold	139,332	–	–	0.19%	71
2021 Q3	$825K	Buy	139,332 +3,700	+3%	+$26.6K	0.22%	69
2021 Q2	$1.48M	Buy	+135,632	New	+$1.68M	0.31%	63

Other funds holding LVTX

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Cannell Capital Alta, Wyoming $154M AUM 40.62% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return